These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 9551909)

  • 1. Aberrant intermolecular disulfide bonding in a mutant HLA-DM molecule: implications for assembly, maturation, and function.
    Busch R; Doebele RC; von Scheven E; Fahrni J; Mellins ED
    J Immunol; 1998 Jan; 160(2):734-43. PubMed ID: 9551909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variation in HLA-DM expression influences conversion of MHC class II alpha beta:class II-associated invariant chain peptide complexes to mature peptide-bound class II alpha beta dimers in a normal B cell line.
    Ramachandra L; Kovats S; Eastman S; Rudensky AY
    J Immunol; 1996 Mar; 156(6):2196 - 2204. PubMed ID: 8690909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of aberrant association of DM with MHC class II subunits in the absence of invariant chain.
    Neumann J; König A; Koch N
    Int Immunol; 2007 Jan; 19(1):31-9. PubMed ID: 17105964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of HLA-DM transfection on hen egg lysozyme presentation by T2.Ak cells.
    Albert LJ; Ghumman B; Watts TH
    J Immunol; 1996 Sep; 157(6):2247-55. PubMed ID: 8805621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Editing of the HLA-DR-peptide repertoire by HLA-DM.
    Kropshofer H; Vogt AB; Moldenhauer G; Hammer J; Blum JS; Hämmerling GJ
    EMBO J; 1996 Nov; 15(22):6144-54. PubMed ID: 8947036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-DM is present in one-fifth the amount of HLA-DR in the class II peptide-loading compartment where it associates with leupeptin-induced peptide (LIP)-HLA-DR complexes.
    Schafer PH; Green JM; Malapati S; Gu L; Pierce SK
    J Immunol; 1996 Dec; 157(12):5487-95. PubMed ID: 8955198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The intracellular transport of MHC class II molecules in the absence of HLA-DM.
    Green JM; DeMars R; Xu X; Pierce SK
    J Immunol; 1995 Oct; 155(8):3759-68. PubMed ID: 7561080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-DM can partially replace the invariant chain for HLA-DR transport and surface expression in transfected endocrine epithelial cells.
    Serradell L; Muntasell A; Catálfamo M; Martí M; Costa M; de Préval C; Jaraquemada D
    Tissue Antigens; 1999 May; 53(5):447-58. PubMed ID: 10372540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A role for HLA-DO as a co-chaperone of HLA-DM in peptide loading of MHC class II molecules.
    Kropshofer H; Vogt AB; Thery C; Armandola EA; Li BC; Moldenhauer G; Amigorena S; Hämmerling GJ
    EMBO J; 1998 Jun; 17(11):2971-81. PubMed ID: 9606180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The inability of the nonobese diabetic class II molecule to form stable peptide complexes does not reflect a failure to interact productively with DM.
    Peterson M; Sant AJ
    J Immunol; 1998 Sep; 161(6):2961-7. PubMed ID: 9743359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformational alterations during biosynthesis of HLA-DR3 molecules controlled by invariant chain and HLA-DM.
    Verreck FA; Fargeas CA; Hämmerling GJ
    Eur J Immunol; 2001 Apr; 31(4):1029-36. PubMed ID: 11298327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3.
    Ghosh P; Amaya M; Mellins E; Wiley DC
    Nature; 1995 Nov; 378(6556):457-62. PubMed ID: 7477400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polarized transport of MHC class II molecules in Madin-Darby canine kidney cells is directed by a leucine-based signal in the cytoplasmic tail of the beta-chain.
    Simonsen A; Pedersen KW; Nordeng TW; von der Lippe A; Stang E; Long EO; Bakke O
    J Immunol; 1999 Sep; 163(5):2540-8. PubMed ID: 10452991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invariant chain association with MHC class I: preference for HLA class I/beta 2-microglobulin heterodimers, specificity, and influence of the MHC peptide-binding groove.
    Vigna JL; Smith KD; Lutz CT
    J Immunol; 1996 Nov; 157(10):4503-10. PubMed ID: 8906828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An essential role for HLA-DM in antigen presentation by class II major histocompatibility molecules.
    Morris P; Shaman J; Attaya M; Amaya M; Goodman S; Bergman C; Monaco JJ; Mellins E
    Nature; 1994 Apr; 368(6471):551-4. PubMed ID: 8139689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality control of MHC class II associated peptides by HLA-DM/H2-M.
    Vogt AB; Arndt SO; Hämmerling GJ; Kropshofer H
    Semin Immunol; 1999 Dec; 11(6):391-403. PubMed ID: 10625593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of the HLA-DM interaction site on HLA-DR molecules.
    Doebele RC; Busch R; Scott HM; Pashine A; Mellins ED
    Immunity; 2000 Oct; 13(4):517-27. PubMed ID: 11070170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting signal and subcellular compartments involved in the intracellular trafficking of HLA-DMB.
    Copier J; Kleijmeer MJ; Ponnambalam S; Oorschot V; Potter P; Trowsdale J; Kelly A
    J Immunol; 1996 Aug; 157(3):1017-27. PubMed ID: 8757605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acquisition of peptides by MHC class II polypeptides in the absence of the invariant chain.
    Hitzel C; van Endert P; Koch N
    J Immunol; 1995 Feb; 154(3):1048-56. PubMed ID: 7822782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DM-mediated release of a naturally occurring invariant chain degradation intermediate from MHC class II molecules.
    Stebbins CC; Peterson ME; Suh WM; Sant AJ
    J Immunol; 1996 Dec; 157(11):4892-8. PubMed ID: 8943393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.